Clinical Trial Update: Promoting Enhanced Pharmacotherapy Choice Through Immunomarkers Evaluation in Depression [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating immunomarkers to guide pharmacotherapy in depression was terminated; results posted previously.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Depression | Phase 4 | Status: TERMINATED | Results posted: 2023-04-18